New targeted drug shows promise for Hard-to-Treat cancers
Disease control
Recruiting now
This study tests a new drug called 3H-10000 in people with advanced lung or stomach cancer that cannot be removed by surgery or has spread. The drug is designed to target and kill cancer cells while limiting harm to healthy cells. The trial will check for side effects, find the b…
Phase: PHASE1, PHASE2 • Sponsor: 3H Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC